Evidence map›Paper›PMID 40955783›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Closed-Loop Bioelectronic Artificial Pancreas Patch for Continuous Monitoring and Regulation of Blood Glucose in Diabetic Rats and Pigs.

Yiqun Liu, Changxi Zhang, Lingyi Xu, Yuan Ma, Yuanyuan Ma, Ying Chen, Difei Lu, Le Ye, Li Yang, Yue Cui

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yiqun LiuSchool of Materials Science and Engineering, Peking University, Beijing, 100871, P. R. China.
Changxi ZhangSchool of Materials Science and Engineering, Peking University, Beijing, 100871, P. R. China.
Lingyi XuRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, 100034, P. R. China.
Yuan MaRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, 100034, P. R. China.
Yuanyuan MaLaboratory Animal Center, Peking University First Hospital, Beijing, 100034, P. R. China.
Ying ChenRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, 100034, P. R. China.
Difei LuDepartment of Endocrinology, Peking University First Hospital, Beijing, 100034, P. R. China.
Le YeSchool of Integrated Circuits, Peking University, Beijing, 100871, P. R. China.
Li YangRenal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, 100034, P. R. China.
Yue CuiSchool of Materials Science and Engineering, Peking University, Beijing, 100871, P. R. China.ORCID https://orcid.org/0000-0003-0768-5930

Funding

Beijing Science and Technology Planning Projec Z241100009024052Beijing Young Scientist Program BJJWZYJH01201910001006Capital's Funds for Health Improvement and Research CFH2022-1-4071National Key R&D Program of China 2022YFB3204400National Natural Science Foundation of China 52072007State Key Laboratory of Vascular Homeostasis and Remodeling of Peking University
6 · The paper itself

Abstract

Integrated artificial pancreas devices with continuous glucose monitoring (CGM) and closed-loop insulin delivery are crucial for diabetes management. However, design challenges remain, including miniaturization, low cost, stability, and low power consumption. Current commercial products are expensive ($3,000 to $8,000 USD), and bulky, typically exceeding 100 cm

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, ExperimentalPancreas, ArtificialAnimalsEquipment DesignInsulinInsulin Infusion SystemsRatsRats, Sprague-DawleySwineBlood GlucoseInsulinartificial pancreasclosed‐loopdiabetesglucose sensorinsulin pump

Identifiers

PMID40955783
PMCPMC12667471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.